Open AccessPB1753: SYNERGISTIC ANTITUMOR EFFECT OF CHIDAMIDE WITH VENETOCLAX IN T‐CELL ACUTE LYMPHOBLASTIC LEUKEMIA BY SUPPRESSING PI3K/AKT SIGNALING
Author(s) -
Song D.,
Song C.,
Ge Z.
Publication year - 2022
Publication title -
hemasphere
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.677
H-Index - 11
ISSN - 2572-9241
DOI - 10.1097/01.hs9.0000849868.89934.c9
Subject(s) - propidium iodide , cancer research , cell growth , mantle cell lymphoma , protein kinase b , ibrutinib , flow cytometry , apoptosis , cell cycle , chemistry , pi3k/akt/mtor pathway , venetoclax , leukemia , biology , microbiology and biotechnology , lymphoma , chronic lymphocytic leukemia , immunology , programmed cell death , biochemistry